| -Omics and cancer biomarkers: link to the biological truth or bear the consequences LA Liotta, EF Petricoin III Cancer Epidemiology, Biomarkers & Prevention 21 (8), 1229-1235, 2012 | 26 | 2012 |
| “Clinical Proteomics” in Molecular Genetic Pathology DH Geho, V Espina, LA Liotta, EF Petricoin, JD Wulfkuhle Molecular Genetic Pathology, 369, 2008 | 1 | 2008 |
| 1, 2, 3-triazole and imidazole compounds and their antitumor use EC Kohn, LA Liotta, CC Felder | 1 | 1993 |
| 1081: Signal Pathway Profiles Based on Histologic Grade of Human Prostate Cancer Using Reverse Phase Protein Microarrays RL Grubb, VS Calvert, JD Wulfkuhle, CP Paweletz, JW Gillespie, ... The Journal of Urology 171 (4S), 285-285, 2004 | | 2004 |
| 11q13 Allelotype analysis in 27 northern american MEN1 kindreds identifies two distinct founder chromosomes MR Emmert-Buck, LV Debelenko, S Agarwal, MB Kester, P Manickam, ... Molecular genetics and metabolism 63 (2), 151-155, 1998 | 10 | 1998 |
| 12. INTERACTION OF TUMOR CELLS WITH BASEMENT MEMBRANES AND LAMININ-1 GR MARTIN¹, LA Liotta, HK Kleinman Laminins 2, 277, 1996 | 13 | 1996 |
| 128 5-Azacytidine induces STAT-5 activation through PLC-y1Tyr783 A Romano, C Giallongo, P La Cava, A Branca, C Vetro, NL Parrinello, ... Leukemia Research, S49-S50, 2011 | | 2011 |
| 15. The The application of novel technology to the study of ovarian cancer MR Brown, M Emmert-Buck, DB Krizman, E Petricoin, LA Liotta, EC Kohn Ovarian Cancer, 107, 2002 | | 2002 |
| 17 Pattern Recognition Algorithms and Disease Biomarkers BA Hitt, E Petricoin, L Liotta Informatics In Proteomics, 353, 2005 | | 2005 |
| 17Pattern Recognition BA Hitt, E Petricoin, L Liotta Informatics in Proteomics, 353, 0 | | |
| 198 ADVANCES IN THE BIOLOGY OF DISEASE LA Liotta Advances in the Biology of Disease 1 (335), 197, 1984 | | 1984 |
| 2.29 Circulating CLL Cells Expressing Markers of Clinical Aggressiveness Display a Phosphoproteomic Profile Consistent with a Constitutive Receptor Engagement D Benedetti, A Zucchetto, E Tissino, D Marconi, M Dal Bo, R Bomben, ... Clinical Lymphoma, Myeloma and Leukemia 11, S177-S178, 2011 | | 2011 |
| 260 T cell infiltrating repertoire diversity is associated with enhanced survival following neoadjuvant therapy in patients with resectable pancreatic cancer P Murthy, P Saini, K Russell, W Pan, D Weber, M Byrne-Steele, J Han, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
| 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers G Zhou, H Li, D DeCamp, S Chen, H Shu, Y Gong, M Flaig, JW Gillespie, ... Molecular & Cellular Proteomics 1 (2), 117-123, 2002 | 607 | 2002 |
| 3 Overview of proteomics with emphasis on diagnosis and monitoring EC Kohn, EM Posadas, V Espina, V Kwitkowski, B Davidson, EF Petricoin, ... EJC Supplements 8 (2), 3, 2004 | | 2004 |
| 358 Proteomic pattern analysis serum for early detection of ovarian cancer EC Kohn, EF Petricoin, G Whiteley, G Mills, LA Liotta EJC Supplements 5 (1), S110, 2003 | | 2003 |
| 43 Applications of Proteomics to Metastasis Diagnosis and Individualized Therapy M Pierobon, A Luchini, A Silvestri, V Espina, EF Petricoin, LA Liotta Cancer Metastasis: Biologic Basis and Therapeutics, 475, 2011 | | 2011 |
| 44Ki44OO44Kk44Kt44K577ya55mM44Go5a6/54Sh44GX57Sw6IOe LA Liotta, E Kohn Nature Digest 1 (10), 13-14, 2004 | | 2004 |
| 7 MECHANISMS OF CANCER INVASION AND METASTASES LANCE A. LIOTTA LA LIOTTA Influence of Tumor Development on the Host 3, 58, 1989 | | 1989 |
| 730 PROTEOMICS BIOMARKERS PREDICTING HISTOLOGIC NON-ALCOHOLIC STEATOHEAPTITIS AND FIBROSIS Z Younossi, A Baranova, M Stepanova, VS Calvert, A Afendy, Z Goodman, ... Journal of Hepatology, S266-S267, 2009 | | 2009 |